# Black Bird Biotech, Inc. (BBBT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BBBT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 26.2K | $ -842.7K | $ -128.5K | $ 748.1K | $ -922.8K |
| 2022 | $ 92.2K | $ -1.91M | $ -1.15M | $ 669.8K | $ -650.2K |
| 2021 | $ 124.2K | $ -2.15M | $ -1.19M | $ 58.3K | $ 670.2K |
| 2020 | $ 73.4K | $ -879.2K | $ -789.8K | $ 45.6K | $ 27.6K |
| 2019 | $ 22.9K | $ -157.4K | $ -111.4K | $ 874.6K | $ -1.14M |
| 2018 | $ 0 | $ -159.9K | $ -100.5K | $ 792.0K | $ -1.02M |
| 2017 | $ 0 | $ -148.2K | $ -102.0K | $ 712.8K | $ -897.7K |
| 2016 | $ 0 | $ -146.2K | $ -107.2K | $ 650.0K | $ -787.7K |
| 2015 | $ 0 | $ -157.9K | $ -112.6K | $ 570.0K | $ -681.4K |
| 2014 | $ 0 | $ -140.6K | $ -115.2K | $ 500.0K | $ -569.0K |
| 2013 | $ 33.8K | $ -128.0K | $ -111.6K | $ 420.0K | $ -469.4K |
| 2012 | $ 0 | $ -124.9K | $ -97.0K | $ 340.0K | $ -379.5K |
| 2011 | $ 1.64M | $ -235.3K | $ 246.6K | $ 300.0K | $ -292.9K |
| 2010 | $ 1.05M | $ -12.53M | $ -1.11M | $ 619.7K | $ -132.8K |
| 2009 | $ 0 | $ -255.5K | $ -242.2K | $ 0 | $ 26.6K |
| 2008 | $ 0 | $ -35.2K | $ -35.0K | $ 225 | $ 3.2K |
| 2007 | $ 0 | $ -54.6K | $ -54.5K | $ 0 | $ 21.4K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.81 |
| Liabilities / Eq | -1.11 |
| Current Ratio | 0.09 |

## Other views

- [Metrics](https://sponda.capital/en/BBBT.md)
- [Charts](https://sponda.capital/en/BBBT/charts.md)
- [Compare](https://sponda.capital/en/BBBT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.